Irisin reduces AS aggregation : ... - Cure Parkinson's

Cure Parkinson's

25,478 members26,801 posts

Irisin reduces AS aggregation

Little_apple profile image
0 Replies

Amelioration of pathologic α-synuclein-induced Parkinson’s disease by irisin

Irisin is an exercise-induced polypeptide secreted by skeletal muscle that crosses the blood–brain barrier and mediates certain effects of exercise. Here, we show that irisin prevents pathologic α-synuclein (α-syn)-induced neurodegeneration in the α-syn preformed fibril (PFF) mouse model of sporadic PD. Intravenous delivery of irisin via viral vectors following the stereotaxic intrastriatal injection of α-syn PFF cause a reduction in the formation of pathologic α-syn and prevented the loss of dopamine neurons and lowering of striatal dopamine. Irisin also substantially reduced the α-syn PFF-induced motor deficits as assessed behaviorally by the pole and grip strength test. Recombinant sustained irisin treatment of primary cortical neurons attenuated α-syn PFF toxicity by reducing the formation of phosphorylated serine 129 of α-syn and neuronal cell death. Tandem mass spectrometry and 

pnas.org/doi/10.1073/pnas.2...

Green cardamom supplementation improves serum irisin, glucose indices, and lipid profiles in overweight or obese non-alcoholic fatty liver disease patients: a double-blind randomized placebo-controlled clinical trial

ncbi.nlm.nih.gov/pmc/articl...

Exercise is known to have positive effects on brain health, which is why identifying key mediators of those neuroprotective benefits, like irisin, has become such a critical goal of research,” said Wrann, who also serves as an HMS assistant professor 

hsci.harvard.edu/news/hormo...

Written by
Little_apple profile image
Little_apple
To view profiles and participate in discussions please or .
Read more about...

You may also like...

Glycine : said to reduce symptoms and reduce aggregation

pilot clinical trial https://onlinelibrary.wiley.com/doi/10.1002/ctm2.372...

Shining a light on Protein Aggregation in Parkinson's Disease

vitamin B3 has long been recognized as a key mediator of neuronal development and survival. Niacin...

Copper Leads to Protein Aggregation in Parkinson’s Disease

July 7 2022 https://neurosciencenews.com/copper-parkinsons-20979/ \\"Summary: Alpha-synuclein...

Parkinson's Disease: emerging treatment target, the NLRP inflammasome.

the gradual death of dopamine-producing neurons but also recruit more pathological proteins,...

Zhittya Genesis Medicine's Drug Reverses Aggregated Synuclein Accumulation in an Animal Model of Parkinson's Disease

functional dopamine-secreting neurons as well as elimination of toxic aggregates of the...